Heron Therapeutics, Inc. · NASDAQ:HRTX

Duarte Ira exercised options for 25,229 Heron Therapeutics, Inc. shares (Form 4)

Traded Jul 30 to Jul 31, 2026 · Filed Aug 3, 2026

From Jul 30 to Jul 31, 2026, Duarte Ira (EVP, Chief Financial Officer) exercised options for 25,229 Heron Therapeutics, Inc. shares, leaving 281,899 shares. Filed Aug 3, 2026 (Form 4).

Options exercised
25,229 shares
Holding after
281,899 shares
Trading plan
No
Role
EVP, Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 30, 2026Common StockOption exercise13,535277,381Direct
Jul 30, 2026Common StockShares withheld for tax3,850US$0.50273,531Direct
Jul 31, 2026Common StockOption exercise11,694285,225Direct
Jul 31, 2026Common StockShares withheld for tax3,326US$0.50281,899Direct

Source

View original at SEC

Related